Article
Harnessing the endogenous Type I-C CRISPR-Cas system for genome editing in <i>Bifidobacterium breve</i>
2023-09-26
Abstract excerpt
Bifidobacterium breve , one of the main bifidobacterial species colonizing the human gastrointestinal tract in early life, has received extensive attention for its purported beneficial effects on human health. However, exploration of the mode of action of such beneficial effects exerted by B. breve is cumbersome due to the lack of effective genetic tools, which limits its synthetic biology application. Given the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9cdcb505-ef32-5548-aaf6-5a5d6a1945c2
- DOI
- 10.1101/2023.09.25.559376
